CELL.V Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: June 27, 2025
Report Source: 2025 3rd Quarter Report
Grid Battery Metals Inc. Stock Analysis CELL.V
Grid Battery Metals, Inc. engages in the acquisition, exploration, and development of mineral resources. The company is headquartered in Coquitlam, British Columbia. The company went IPO on 2013-04-18. The firm maintains a focus on exploration for high value battery metals required for the electric vehicle (EV) market. The firm acquired a 100% interest in Grid Copper Project, which consists of 17 mineral claims comprising 27,525 hectares (approximately 275 square kilometers (km2)) located in North Central British Columbia. The firm owns a 100% interest in the Texas Spring Property, which consists of mineral lode claims located in Elko County, Nevada. The target is a lithium clay deposit in volcanic tuff and tuffaceous sediments of the Humbolt Formation. The firm also has a 100% interest in 113 lithium lode and placer claims covering over 930 hectares in Clayton Valley. The firm also owns a 100% interest in Volt Canyon Lithium Property, which has over 80 placer claims covering approximately 635 hectares of alluvial sediments and clays located 122 km northeast of Tonopah, Nevada.
Read More Grid Battery Metals Inc (CELL.V) Chart
Key Statistics of Grid Battery Metals Inc (CELL.V)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.02Volume
13.56KP/E Ratio (TTM)
-52 Week Range
Market Cap
4.83MAvg. Volume
67.39KDividend Yield
-Financial Metrics & Statements of Grid Battery Metals Inc (CELL.V)
FAQ's for Grid Battery Metals Inc (CELL.V)
- According to Musaffa’s Shariah screening methodology, Grid Battery Metals Inc (CELL.V) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.